73 related articles for article (PubMed ID: 11245438)
1. Frequent mutations of Fas gene in thyroid lymphoma.
Takakuwa T; Dong Z; Takayama H; Matsuzuka F; Nagata S; Aozasa K
Cancer Res; 2001 Feb; 61(4):1382-5. PubMed ID: 11245438
[TBL] [Abstract][Full Text] [Related]
2. Frequent mutations of Fas gene in nasal NK/T cell lymphoma.
Takakuwa T; Dong Z; Nakatsuka S; Kojya S; Harabuchi Y; Yang WI; Nagata S; Aozasa K
Oncogene; 2002 Jul; 21(30):4702-5. PubMed ID: 12096347
[TBL] [Abstract][Full Text] [Related]
3. Aberrant somatic hypermutations in thyroid lymphomas.
Takakuwa T; Miyauchi A; Aozasa K
Leuk Res; 2009 May; 33(5):649-54. PubMed ID: 19019431
[TBL] [Abstract][Full Text] [Related]
4. Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder.
Lee SH; Shin MS; Park WS; Kim SY; Dong SM; Pi JH; Lee HK; Kim HS; Jang JJ; Kim CS; Kim SH; Lee JY; Yoo NJ
Cancer Res; 1999 Jul; 59(13):3068-72. PubMed ID: 10397246
[TBL] [Abstract][Full Text] [Related]
5. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer.
Lee SH; Shin MS; Park WS; Kim SY; Kim HS; Han JY; Park GS; Dong SM; Pi JH; Kim CS; Kim SH; Lee JY; Yoo NJ
Oncogene; 1999 Jun; 18(25):3754-60. PubMed ID: 10391683
[TBL] [Abstract][Full Text] [Related]
6. [Hypermethylation of DAP-kinase gene CpG Island in malignant lymphoma with B-cell phenotype].
Nakatsuka S; Takakuwa T; Aozasa K
Rinsho Byori; 2001 Dec; 49(12):1242-7. PubMed ID: 11797395
[TBL] [Abstract][Full Text] [Related]
7. Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma.
Shin MS; Park WS; Kim SY; Kim HS; Kang SJ; Song KY; Park JY; Dong SM; Pi JH; Oh RR; Lee JY; Yoo NJ; Lee SH
Am J Pathol; 1999 Jun; 154(6):1785-91. PubMed ID: 10362803
[TBL] [Abstract][Full Text] [Related]
8. Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer.
Boldrini L; Faviana P; Pistolesi F; Gisfredi S; Di Quirico D; Lucchi M; Mussi A; Angeletti CA; Baldinotti F; Fogli A; Simi P; Basolo F; Fontanini G
Oncogene; 2001 Oct; 20(45):6632-7. PubMed ID: 11641789
[TBL] [Abstract][Full Text] [Related]
9. Polymerase chain reaction-based clonality analysis in thyroid lymphoma.
Yamauchi A; Tomita Y; Takakuwa T; Hoshida Y; Nakatsuka S; Sakamoto H; Aozasa K
Int J Mol Med; 2002 Jul; 10(1):113-7. PubMed ID: 12060861
[TBL] [Abstract][Full Text] [Related]
10. Role of hypermethylation of DAP-kinase CpG island in the development of thyroid lymphoma.
Nakatsuka S; Takakuwa T; Tomita Y; Miwa H; Matsuzuka F; Aozasa K
Lab Invest; 2000 Nov; 80(11):1651-5. PubMed ID: 11092525
[TBL] [Abstract][Full Text] [Related]
11. Expression of interleukin-7 and its receptor in thyroid lymphoma.
Takakuwa T; Nomura S; Matsuzuka F; Inoue H; Aozasa K
Lab Invest; 2000 Oct; 80(10):1483-90. PubMed ID: 11045564
[TBL] [Abstract][Full Text] [Related]
12. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
[TBL] [Abstract][Full Text] [Related]
13. Infrequent somatic Fas mutations but no evidence of Bcl10 mutations or t(11;18) in primary cutaneous MALT-type lymphoma.
Grønbaek K; Ralfkiaer E; Kalla J; Skovgaard GL; Guldberg P
J Pathol; 2003 Sep; 201(1):134-40. PubMed ID: 12950026
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1.
Inaba H; Shimada K; Zhou YW; Ido M; Buck S; Yonehara S; Kaplan J; Komada Y
Int J Oncol; 2005 Aug; 27(2):573-9. PubMed ID: 16010441
[TBL] [Abstract][Full Text] [Related]
15. Immunologic and immunohistochemical studies on chronic lymphocytic thyroiditis with or without thyroid lymphoma.
Aozasa K; Tajima K; Tominaga N; Katagiri S; Yonezawa T; Matsuzuka F; Kuma K; Sawada M
Oncology; 1991; 48(1):65-71. PubMed ID: 1987500
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability and k-ras, p53 mutations in thyroid lymphoma.
Takakuwa T; Hongyo T; Syaifudin M; Kanno H; Matsuzuka F; Narabayashi I; Nomura T; Aozasa K
Jpn J Cancer Res; 2000 Mar; 91(3):280-6. PubMed ID: 10760686
[TBL] [Abstract][Full Text] [Related]
17. DNA sequence of immunoglobulin heavy chain variable region gene in thyroid lymphoma.
Miwa H; Takakuwa T; Nakatsuka S; Tomita Y; Matsuzuka F; Aozasa K
Jpn J Cancer Res; 2001 Oct; 92(10):1041-7. PubMed ID: 11676854
[TBL] [Abstract][Full Text] [Related]
18. Fas gene mutations in mycosis fungoides: analysis of laser capture-microdissected specimens from cutaneous lesions.
Nagasawa T; Takakuwa T; Takayama H; Dong Z; Miyagawa S; Itami S; Yoshikawa K; Aozasa K
Oncology; 2004; 67(2):130-4. PubMed ID: 15539917
[TBL] [Abstract][Full Text] [Related]
19. A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphoma.
van Doorn R; Dijkman R; Vermeer MH; Starink TM; Willemze R; Tensen CP
Cancer Res; 2002 Oct; 62(19):5389-92. PubMed ID: 12359741
[TBL] [Abstract][Full Text] [Related]
20. Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation.
Mitsiades CS; Poulaki V; Fanourakis G; Sozopoulos E; McMillin D; Wen Z; Voutsinas G; Tseleni-Balafouta S; Mitsiades N
Clin Cancer Res; 2006 Jun; 12(12):3705-12. PubMed ID: 16778096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
